Call for proposals
Unitaid to double its investment in maternal and newborn health with call for proposals that address preeclampsia and anemia
Click here!
×
EN
FR
COVID-19 UPDATE
English
Français
About us
Strategy
Governance
Secretariat
Careers
How we work
Partners
Countries
Donors
Grantees
Communities
Apply for funding
Our projects
Core Investment Areas
View Projects
Our impact
Evaluations
News
Press releases
Statements
Newsletters
Videos
Podcasts
Stories
Publications
Contact
World AMR Awareness Week
With antimicrobial resistance, women and children face highest risks
Read more
Antimicrobial resistance (AMR)
Unitaid's work in AMR
Learn more about
Call for Proposals:
Improving access to lifesaving tools for prevention, diagnosis, and management of pre-eclampsia and maternal anemia
Read more
COP29 spotlight:
How Unitaid can reduce emissions in HIV treatment
Read more
The last mile in child medicine:
The best HIV medicines for the youngest babies
Explore our photo story!
Marking World Oxygen Day:
Expanding access to lifesaving oxygen for newborns
Find out more
PANDEMIC PREVENTION, PREPAREDNESS AND RESPONSE
Area
Tuberculosis
Area
MALARIA
Area
HIV and coinfections
Area
Medical Oxygen
AREA
Climate and Health
AREA
Universal Health Coverage
AREA
Regional Manufacturing
AREA
Women’s and children’s health
AREA
Calls for proposals
Learn More
Featured News
28 November 2024
From promise to impact: Unlocking lenacapavir’s potential to end HIV
Read More
28 November 2024
Unitaid invests US$22m to accelerate access to lenacapavir, a groundbreaking new HIV prevention drug
Read More
22 November 2024
With antimicrobial resistance, women and children face highest risks
Read More
21 November 2024
Unitaid to double its investment in maternal and newborn health with call for proposals that address preeclampsia and anemia
Read More
View More news
Featured Videos
Why Unitaid?
About Unitaid (Saving lives faster)
MTVShugaBabi. Bande-annonce
Innovating to fight drug resistance
View All Videos
Sign Up for Unitaid Updates
First Name
*
Last Name
*
Email Address
*
Comments
This field is for validation purposes and should be left unchanged.
